Tags: Drug.
Rilotumumab is a human monoclonal antibody designed for the treatment of solid tumors.Rilotumumab was developed by Amgen Inc.
Loading...
This page contains content from the copyrighted Wikipedia article "Rilotumumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.